Relevant Thesis-Based Degree Programs
Graduate Student Supervision
Doctoral Student Supervision
Dissertations completed in 2010 or later are listed below. Please note that there is a 6-12 month delay to add the latest dissertations.
Advancing equity, diversity, and inclusion in arthritis research: a mixed-methods exploration of strategies for improvement and integration (2026)
The full abstract for this thesis is available in the body of the thesis, and will be available when the embargo expires.
View record
Impact of cancer on sexual and reproductive health among adolescent and young adults (AYA): epidemiologic studies and patients’ perspectives (2025)
Objectives: To use multi-method approaches across quantitative and qualitative studies to comprehensively evaluate impacts of AYA cancer on sexual and reproductive health outcomes and experiences.Methods: I conducted: 1) Systematic reviews and meta-analyses; 2) Epidemiologic studies using administrative health databases to evaluate associations between female colorectal cancer (CRC), and reproductive and sexual health outcomes; and 3) Serial focus groups with AYA cancer patients, grouped by shared characteristics and analyzed with framework methodology.Results: 1) Systematic review and meta-analysis showed associations between AYA cancer and reproductive health outcomes: gestational diabetes (pooled odds ratio (pOR) 1.43; 95% confidence interval (CI): 1.03, 1.99) and fertility treatment (pOR 2.66; 95% CI: 1.71, 4.11); and sexual health outcomes: vaginal dryness (pOR 3.94; 95% CI: 2.02, 7.70), ejaculatory dysfunction (pOR 3.66; 95% CI: 2.20, 6.08), and testosterone level (mean difference = -2.56 nmol/l; 95% CI: -3.46, -1.66; p = 0.00001).2) Exploring reproductive health outcomes, females with ≥2 births in the 5-year prodrome had 1.82x the odds of early-age onset CRC (EAO-CRC) compared to those with no births (OR 1.82; 95% CI: 1.19, 2.78). Post-diagnosis, females with EAO-CRC had lower odds of giving birth within 5 years (OR 0.23; 95% CI 0.15, 0.37) compared to females with no EAO-CRC. For sexual health outcomes, females diagnosed with CRC ≤39 years had higher risk of premature ovarian failure (HR 1.75; 95% CI: 1.40, 2.19), dyspareunia (HR 1.90; 95% CI: 1.58, 2.28), abnormal bleeding (HR 0.74; 95% CI: 0.59, 0.93), and pelvic inflammatory disease (HR 1.67; 95% CI: 1.08, 2.57) compared to females without CRC.3) Eight focus group cohorts of AYA cancer patients, with 3 – 10 participants each (N = 38 females, 10 males). Themes described participants’ experiences as: internal impacts of AYA cancer on sexual and reproductive health and external impacts on relationships. Themes indicated health care systems enablers and individual-level factors influencing access to sexual and reproductive health resources and support.Conclusions: Findings offer critical insights into population and individual level impacts of AYA cancer on sexual and reproductive health and suggest intervention opportunities at patient, provider, and policy level to improve care, access, and outcomes.
View record
Exploring health care encounters and treatments for mental disorders in individuals with inflammatory arthritis: epidemiologic and health services research studies (2024)
Objectives: Provide evidence to disentangle the complex relationship between depression and anxiety with inflammatory arthritis (IA) and conduct a comprehensive evaluation of how individuals with IA are treated for comorbid mental disorders.Methods: Four complementary data sources were used: 1) evidence synthesis; 2) population-based administrative health data (Population Data BC); 3) open-source data (Canadian Community Health Survey – Mental Health); and 4) original data (international survey). Descriptive statistics were applied to quantify psychosocial outcomes and describe patterns of health care encounters and treatments for depression and anxiety. Multivariable logistic and linear regression models were used to evaluate associations with outcomes of interest. Results: 1) Numerous case definitions for identifying depression and anxiety using administrative data were applied across the 36 studies in rheumatic diseases synthesized, and case definitions were often unvalidated (83.3%) and insufficiently reported (33.3%). 2a) Health care encounters and medications for depression and anxiety were significantly elevated for individuals with IA during the 5-years before and 5-years after IA diagnosis, as compared to IA-free controls. Odds were highest in the year immediately before (≥1 depression visit: aOR 1.61, 95% CI 1.55-1.66; ≥1 anxiolytic: aOR 1.71, 95% CI 1.66-1.77) or after (≥1 antidepressant: aOR 1.95, 95% CI 1.89-2.00) IA diagnosis. 2b) Half of individuals with IA were receiving minimally adequate pharmacotherapy (depression: 50.5%; anxiety: 46.9%) and one-fifth were receiving adequate psychological treatment (depression: 19.6%; anxiety: 20.2%) for their incident mental disorder, findings that did not significantly differ from IA-free controls (depression: pharmacotherapy – aOR 1.10, 95% CI 1.00-1.21; psychological – aOR 1.07, 95% CI 0.94-1.21). 3) Individuals with arthritis and a comorbid mental disorder have a greater perceived need for mental health care compared to individuals without arthritis (aOR 1.71, 95% CI 1.06-2.77). 4) Symptoms of loneliness and social isolation were respectively experienced by 51% and 30% of individuals with rheumatic diseases and together associated with significantly higher depression (ß= 7.27; 95% CI 6.08-8.47) and anxiety scores (ß = 5.14; 95% CI: 4.00-6.28). Conclusions: Collectively, these findings have addressed critical gaps in rheumatology literature and provide meaningful clinical implications for improving the mental health of people living with IA.
View record
Integrating sex and gender-based analysis in pharmacoepidemiologic studies of medication adherence (2024)
The full abstract for this thesis is available in the body of the thesis, and will be available when the embargo expires.
View record
Adherence to oral anticoagulants in patients with atrial fibrillation (2021)
Objective:The overall aim of this dissertation was to provide a better understanding of adherence to oral anticoagulants (OACs) in patients with atrial fibrillation (AF). Methods:Meta-analysis was used to summarize the current evidence on patients’ adherence. Population-based administrative data of British Columbia (BC) was used to develop a cohort of adults with AF. Random-effects multivariable regression modeling was used to develop and validate a method, called REWarDS, to estimate patient’s individualized daily dose of warfarin and facilitate measurement of adherence to this medication. OAC adherence was measured over follow-up by creating time windows. Group-based trajectory modeling was used to characterize adherence trajectories. Regression analyses were used to identify the factors associated with adherence, and adherence trajectories. Results:Systematic review and meta-analysis found that one year after therapy initiation patients, on average, miss 27% of their doses. REWarDS was found to be accurate with superior performance over current methods for estimating exposure to warfarin. 54% of the patients in the cohort were found to be nonadherent to their OAC, missing, on average, 32% of their doses. The greatest decline in adherence was observed in the first year of therapy. Patients were found to exhibit four distinct long-term adherence trajectories. Being on Vitamin K Antagonist (VKA) was associated with statistically significantly 13% higher adherence compared to being on Direct Oral Anticoagulants (DOAC). Over time, however, adherence increased for DOAC but decreased for VKA. Clinical and demographic factors, while readily available in administrative databases, do not have adequate discriminatory power to predict patients’ adherence trajectories. Conclusion:Adherence in patients with AF was found to be worse than previously understood. Identification of distinct long-term adherence trajectories revealed heterogeneity among nonadherent patients and compels tailoring interventions for different kinds of nonadherence patterns. Findings on the impact of drug class on adherence suggest that prescribers should not assume better adherence for DOACs based on their convenience. Overall, very few variables were identified to be independently associated with any specific adherence trajectory. Altogether, findings call for urgent interventions to improve adherence in patients with AF on both VKA and DOAC, particularly early after therapy initiation.
View record
Safety of perinatal biologic use in autoimmune diseases: population-based studies of maternal and infant outcomes (2018)
Objectives: To examine biologic use before or during pregnancy among women with autoimmune inflammatory disease by: 1) Describing the patterns of use, discontinuation, and 10-year secular trends; 2) Evaluating the association between biologic exposure before or during pregnancy and adverse maternal and infant outcomes including: preterm deliveries, small-for-gestational-age (SGA) births, congenital anomalies, and serious infections; and 3) Reviewing existing literature and meta-analyzing my findings with published results. Methods: Using provincial population-based administrative health data linked with the perinatal registry and prescription dispensations database, a cohort of women with autoimmune inflammatory disease who had at least one pregnancy during 2002-2012 was identified. Descriptive statistics, multivariable modeling, and high-dimensional propensity score (HDPS) methods were used to describe the patterns of perinatal biologic prescriptions and assess associations with outcomes of interest. Results were meta-analyzed with findings from existing literature.Findings: 1) Perinatal biologic use has increased significantly over 10 years, comprising 5.7% of all pregnancies in this population by 2012. Most often women discontinued their biologic in the first (31%), or second (38%) trimesters, while 98% of those on treatment during the second trimester continued through to delivery. Only disease type was associated with discontinuation. 2) After applying HDPS matching, there were no associations observed between biologic use before or during pregnancy and risk of preterm deliveries (OR 1.13, 95% CI 0.67 to 1.90); SGA (OR 0.91, 95% CI 0.46 to 1.78); or congenital anomalies (OR 1.06, 95% CI 0.46 to 2.47). The theoretical concern of serious infections due to immunomodulatory effects of biologics was not observed. 3) Meta-analysis of unadjusted risk estimates showed significantly increased risks of congenital anomalies, preterm deliveries, and low birth weight babies associated with biologic exposure. However, pooled adjusted risk estimates showed no significant associations. Conclusions: Using novel methods to address potential confounding and pooling existing evidence, the findings from this thesis demonstrated that treatment with biologics before or during pregnancy are not associated with a number of important perinatal outcomes. These findings help patients and clinicians weigh risks and benefits of treatment options in pregnancy, and support difficult decision making around using biologics in a vulnerable population.
View record
Master's Student Supervision
Theses completed in 2010 or later are listed below. Please note that there is a 6-12 month delay to add the latest theses.
Understanding experiences of partners of cancer patients (2026)
The full abstract for this thesis is available in the body of the thesis, and will be available when the embargo expires.
View record
Targeted synthetic disease-modifying antirheumatic drugs among mothers with autoimmune disease: pharmacoepidemiologic studies (2025)
The full abstract for this thesis is available in the body of the thesis, and will be available when the embargo expires.
View record
Mental health in people living with and beyond colorectal cancer : a patient-oriented constructivist grounded theory (2023)
Background: Current literature suggests an association between colorectal cancer (CRC) and mental disorders, primarily anxiety and depression. However, gaps in understanding the lived mental health experiences of patients with CRC exist. This thesis aims to explore mental health experiences among patients with CRC across the phases of the CRC care continuum.Objective: 1) To evaluate the risk of mental disorders, namely anxiety and depression, in patients with CRC; 2) to understand and contextualize the specific mental health experiences from the patient perspective at every phase of the CRC care continuum (i.e., acute “treatment” phase, extended “follow-up” phase, permanent “beyond” phase).Methods: For objective 1, I conducted a systematic review and meta-analysis of peer-reviewed studies that: used an epidemiologic design; included patients with CRC and a comparator group of individuals without cancer; and evaluated anxiety and depression as outcomes. For objective 2, I employed a constructivist grounded theory design and conducted semi-structured interviews with participants with CRC to explore their experiences with mental health as well as receiving mental health care, across the phases of the CRC care continuum. Data collection and analysis were iterative, employed theoretical sampling, and culminated in a patient-oriented theoretical model.Results: 1) I quantified the risks and impacts of CRC on anxiety and depression, particularly an increased risk of depression after CRC diagnosis. 2) I constructed a patient-oriented constructivist grounded theory that comprised of these four themes: journeying through CRC, experiencing mental health, receiving care for mental health, and self-identity. Conclusion: This thesis provides novel insight into patients’ mental health experiences in the context of living with CRC. These insights have important implications for comprehensive CRC care, as healthcare providers and cancer care centers can leverage these understandings to provide meaningful change and improve mental health care provision for this patient population.
View record
What are womxn thinking? Understanding perinatal management of rheumatoid arthritis using a feminist epidemiological framework (2020)
INTRODUCTION: Despite recent guidelines for managing rheumatoid arthritis (RA) in pregnancy, high rates of discontinuing medications compatible with pregnancy during the first trimester among patients may suggest a translation gap of emerging clinical knowledge. This thesis aims to provide an understanding of how female patients with RA engage in making medication and reproductive decisions.OBJECTIVES: To understand the perspectives and experiences related to pregnancy and early parenting among female patients with RA and healthcare providers involved in their care (Part 1); and to understand how female patients with RA form decisions related to having children, pregnancy, and medication use (Part 2).METHODS: Part 1: I conducted a systematic review and thematic synthesis of literature about pregnancy and early parenting amongst female patients with inflammatory arthritis, including RA, and their healthcare providers. Part 2: I employed a constructivist grounded theory design and used semi-structured interviews to explore medication and reproductive decision-making in the context of living with RA among a purposive sample of participants. Data collection and analysis were iterative, employed theoretical sampling, and peer debriefing, and culminated in a theoretical model.RESULTS: Part 1: I identified 5 analytical themes among patients – making reproductive and family building decisions; experiencing pregnancy and parenting; navigating caregiving with chronic disease; seeking information and resources for pregnancy planning; and interacting with healthcare providers – and 3 additional analytical themes among providers – providing reproductive health care; interacting with patients; and coordinating patient care with other providers. Part 2: Participants dynamically engaged in four decision-making processes: using medications, having children, planning pregnancy, and parenting. These processes were complexly influenced by their intersecting identities and contextual factors within their decision-making environment, particularly attitudes towards health and medications, disease onset and severity, familial support system, and healthcare provider relationship.CONCLUSION: This thesis provides insight into how patients make reproductive decisions in the context of managing RA with particular emphasis on the patient identity and care experiences. A patient-centred care approach is suggested to support female patients with RA in making better reproductive and medication choices aligning with their individual desires, needs, and values.
View record
Understanding the epidemiology of young-onset colorectal cancer and information needs of patients and survivors (2019)
Introduction: Recent evidence suggests that the risk of young-onset colorectal cancer (yCRC) is significantly increasing. Furthermore, the information needs of this population are not well understood. Unmet information needs are associated with ineffective disease self-management and negative health outcomes. Therefore, it is pertinent to understand the changing epidemiology of yCRC and the information needs of this population.Objectives: This thesis aims 1) to systematically review the literature on the incidence and prevalence trends of yCRC; 2) to determine the information-seeking behaviours of individuals with yCRC; and 3) to determine the information needs of individuals with yCRC. Methods: To address Objective 1, a systematic review was conducted. Databases were searched for studies that: used an epidemiologic design, assessed trends in yCRC incidence or prevalence, and published in English. To address Objective 2, descriptive statistics and proportions of information-seeking behaviours were reported. Lastly, Objective 3 was addressed by reporting proportions of information items unmet. Predictors of corresponding unmet information needs were assessed using multivariable logistic regression models. Results: 1) The search returned 8,695 articles with 40 studies from 12 countries across five continents. Thirty-nine studies assessed trends in yCRC incidence and only one study prevalence trends. Noteworthy, 17 studies from North America and Oceania consistently reported increasing incidence trends in yCRC. Among studies assessing cancer site, nine (of 14) showed an increased risk of rectal cancer in adults less than 50 years. 2) A sample of 366 yCRC respondents, predominantly consisting of highly-educated white women, was analyzed. At respondents’ most recent search of yCRC information (N= 323), 143 respondents relied on the Internet. 3) Among 39 information need items, 26 unmet information needs were found. Conclusion: This thesis provided evidence that risk of yCRC is increasing predominantly in North America and Oceania, driven by rising rectal cancers in younger adults over the past two decades. In addition, this thesis reports that the information needs of the recruited sample were substantially unmet.
View record
Management of gout from the patient perspective (2017)
Introduction: Suboptimal medication adherence and poor health outcomes in patients with gout, the most common inflammatory arthritis, has prompted efforts to optimize care delivery. The Virtual Gout Clinic, an electronic health technology supported collaborative care model for gout involving rheumatology, pharmacy, and dietetics, offers a promising solution. The purpose of this thesis is to gain an in-depth understanding of how individuals engage in managing their gout and also explore the complexity of the Virtual Gout Clinic using mixed methods to optimize the context and delivery of this care model.Objectives: 1) To explore individual experiences with gout in a Canadian population and to understand the phenomenon of becoming actively engaged in the management of gout with an emphasis on factors which facilitate management; and 2) to explore how participants with gout experience the Virtual Gout Clinic and to understand and explain quantitative outcomes from the evaluation of this care model.Methods: For the first objective, I used a constructivist grounded theory design and conducted semi-structured telephone interviews with participants diagnosed with gout completing the Virtual Gout Clinic. I applied an explanatory sequential mixed methods design for objective 2, as this design enables interview questions used in the qualitative component to be informed by quantitative outcomes of the Virtual Gout Clinic (adherence, serum uric acid) for a comprehensive final interpretation. Results: 1) Analysis of 12 interviews constructed four themes: describing the severity of gout; processing the diagnosis and management of gout; interfering with management of gout; and facilitating management of gout. 2) The experience of the Virtual Gout Clinic was described by three conceptual categories: learning through the Virtual Gout Clinic; receiving personalized support; and knowing someone cares. Suboptimal health outcomes were explained by practical and perceptual barriers to gout management, such as lacking knowledge and fearing side-effects of medications. Conclusion: This thesis provided novel insight into the process of patients becoming actively engaged in the management of gout with an emphasis on facilitating factors. An interdisciplinary model of care is a promising approach to optimize care delivery by providing both emotional and practical support as well as ongoing individualized education.
View record
Pharmaceutical outcomes research to better understand medication non-adherence in patients with Systemic Lupus Erythematosus (2016)
Introduction: This thesis comprises a systematic review and a pharmacoepidemiological study aimed at improving the understanding about medication non-adherence to antimalarials (AM) in Systematic Lupus Erythematosus (SLE). AM is the conventional and effective long-term treatment option that has resulted in substantial decreases in deaths associated with SLE disease activity. However, there seems to be no such decline in the deaths associated with the sequelae of SLE (such as circulatory disease). Since deriving therapeutic effects from AM depends not only on physicians prescribing the appropriate treatment, but also on patients’ adherence with selected treatment, there is the need for a better understanding of medication non-adherence to AM in SLE.Objective: 1) To systematically review and synthesize the literature on medication adherence in SLE to identify key gaps in the literature; and 2) to evaluate the burden and determinants of medication non-adherence to AM in SLE.Methods: To address Objective 1, I have conducted a systematic review. I conducted a mapped search of Medline, Embase, and Web of Science to identify original, observational studies that indicated the data source and measurement tool to assess medication adherence in a SLE patient sample. To address Objective 2, I have conducted a longitudinal pharmacoepidemiological study of a population-based SLE cohort. I used a Cox’s proportional hazard ratio model to examine factors that were significantly associated with discontinuation of AM. Results: 1) 11 studies were included in the systematic review, and the majority of these studies reported that less than 50% of SLE patients are sufficiently adherent to their medications; 2) After five years, only 33% of patients remained on AM therapy; and 3) Higher SES and the following time-varying covariates updated monthly: glucocorticoids use, traditional NSAIDs use, rate of rheumatologist visits, and rate of dermatologists were statistically significantly protective against discontinuation of AM therapy. Conclusion: Altogether as a collective work, this thesis provides evidence that demonstrates medication non-adherence is a substantial problem in SLE. In addition, it highlights the importance of developing adherence interventions to help support patients taking their medications as prescribed.
View record
Current Students & Alumni
If this is your researcher profile you can log in to the Faculty & Staff portal to update your details and provide recruitment preferences.
Membership Status
Program Affiliations
![]()